Kapadia Sandip (CIK 1677141) reported 21 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-01-28). Recent activity: Sell HRMY (3,746 shares), Buy HRMY (3,813 shares), Sell HRMY (2,239 shares), Buy HRMY (4,725 shares), Sell HRMY (2,553 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-01-28 | Harmony Biosciences Holdings, Inc. (HRMY) | CHIEF FINANCIAL OFFICER | Sell | 3,746 | $139,164 |
| 2026-01-26 | Harmony Biosciences Holdings, Inc. (HRMY) | CHIEF FINANCIAL OFFICER | Buy | 3,813 | $0 |
| 2026-01-26 | Harmony Biosciences Holdings, Inc. (HRMY) | CHIEF FINANCIAL OFFICER | Sell | 2,239 | $82,440 |
| 2026-01-26 | Harmony Biosciences Holdings, Inc. (HRMY) | CHIEF FINANCIAL OFFICER | Buy | 4,725 | $0 |
| 2026-01-26 | Harmony Biosciences Holdings, Inc. (HRMY) | CHIEF FINANCIAL OFFICER | Sell | 2,553 | $94,001 |
| 2026-01-20 | Harmony Biosciences Holdings, Inc. (HRMY) | CHIEF FINANCIAL OFFICER | Sell | 20,961 | $752,919 |
| 2025-12-09 | Harmony Biosciences Holdings, Inc. (HRMY) | CHIEF FINANCIAL OFFICER | Buy | 20,000 | $580,600 |
| 2025-12-09 | Harmony Biosciences Holdings, Inc. (HRMY) | CHIEF FINANCIAL OFFICER | Sell | 20,000 | $790,800 |
| 2025-11-25 | Harmony Biosciences Holdings, Inc. (HRMY) | CHIEF FINANCIAL OFFICER | Sell | 3,427 | $119,945 |
| 2025-10-02 | Harmony Biosciences Holdings, Inc. (HRMY) | CHIEF FINANCIAL OFFICER | Buy | 45,000 | $0 |
| 2025-10-02 | Harmony Biosciences Holdings, Inc. (HRMY) | CHIEF FINANCIAL OFFICER | Sell | 24,039 | $662,515 |
| 2025-08-19 | Harmony Biosciences Holdings, Inc. (HRMY) | CHIEF FINANCIAL OFFICER | Sell | 21,573 | $787,414 |
| 2025-04-03 | Harmony Biosciences Holdings, Inc. (HRMY) | CHIEF FINANCIAL OFFICER | Sell | 6,247 | $202,903 |
| 2025-04-03 | Harmony Biosciences Holdings, Inc. (HRMY) | CHIEF FINANCIAL OFFICER | Sell | 740 | $24,509 |
| 2025-04-01 | Harmony Biosciences Holdings, Inc. (HRMY) | CHIEF FINANCIAL OFFICER | Buy | 15,000 | $0 |
| 2025-04-01 | Harmony Biosciences Holdings, Inc. (HRMY) | CHIEF FINANCIAL OFFICER | Sell | 8,014 | $265,985 |
| 2025-01-28 | Harmony Biosciences Holdings, Inc. (HRMY) | CHIEF FINANCIAL OFFICER | Buy | 3,812 | $0 |
| 2025-01-28 | Harmony Biosciences Holdings, Inc. (HRMY) | CHIEF FINANCIAL OFFICER | Sell | 2,037 | $77,426 |
| 2025-01-28 | Harmony Biosciences Holdings, Inc. (HRMY) | CHIEF FINANCIAL OFFICER | Sell | 1,775 | $67,539 |
| 2025-01-23 | Harmony Biosciences Holdings, Inc. (HRMY) | CHIEF FINANCIAL OFFICER | Buy | 25,000 | $725,750 |
| 2025-01-23 | Harmony Biosciences Holdings, Inc. (HRMY) | CHIEF FINANCIAL OFFICER | Sell | 25,000 | $1.0M |
Source: SEC Form 4 filings · as of 2026-01-28